Recently, we identified a GTPase-activating protein for the ADP ribosylation factor family of small GTP-binding proteins that we call GIT1. This protein initially was identified as an interacting partner for the G protein-coupled receptor kinases, and its overexpression was found to affect signaling and internalization of the prototypical ␤2-adrenergic receptor. Here, we report that GIT1 overexpression regulates internalization of numerous, but not all, G protein-coupled receptors. The specificity of the GIT1 effect is not related to the type of G protein to which a receptor couples, but rather to the endocytic route it uses. GIT1 only affects the function of G protein-coupled receptors that are internalized through the clathrin-coated pit pathway in a ␤-arrestin-and dynamin-sensitive manner. Furthermore, the GIT1 effect is not limited to G proteincoupled receptors because overexpression of this protein also affects internalization of the epidermal growth factor receptor. However, constitutive agonist-independent internalization is not regulated by GIT1, because transferrin uptake is not affected by GIT1 overexpression. Thus, GIT1 is a protein involved in regulating the function of signaling receptors internalized through the clathrin pathway and can be used as a diagnostic tool for defining the endocytic pathway of a receptor.
G
protein-coupled receptor function is tightly regulated by numerous downstream signaling events. Agonist stimulation of a G protein-coupled receptor triggers a conformational change allowing activation of coupled G proteins through GDP-GTP exchange (1) . This conformational change also promotes activation of the G protein-coupled receptor kinases (GRKs) to phosphorylate the activated receptor, allowing binding of ␤-arrestin proteins that sterically prevent further coupling to heterotrimeric G proteins (2, 3) . Binding of ␤-arrestins to GRK-phosphorylated G protein-coupled receptors also is believed to initiate receptor sequestration into endosomal recycling compartments (4) . This event appears to be one mechanism by which activated receptors are dephosphorylated and resensitized (3, 5, 6) . We recently identified a GRK-interacting protein that we call GIT1 (GRK-interactor 1) and showed that overexpression of this protein in HEK 293 cells markedly affects signaling and trafficking of the ␤ 2 -adrenergic receptor (␤ 2 AR) (7). Interestingly, GIT1 contains an active ADP ribosylation factor (ARF) GTPase-activating protein domain (GAP) at its amino terminus and binds GRKs through a region located near the carboxyl terminus. The ability of GIT1 to inhibit ␤ 2 AR internalization requires the intact ARF GAP domain, suggesting that GTP-GDP cycling of ARF proteins may be involved in this process (7) . Further, there appear to be at least three members of the GIT protein family, GIT1, GIT2͞CAT2, and PKL (7) (8) (9) , which also interact with the PIX͞PAK complex and with paxillin, as well as PIP 3 lipids (R.T.P., unpublished observations; and N. Vitale, personal communication) (8, 9) . The functional consequences of these interactions for receptor biology still remain to be defined.
In our first report (7), we noted that GIT1 overexpression inhibited ␤ 2 AR internalization. Sequestration of cell surface receptors can occur through different pathways, which differ in the size and the composition of the proto-vesicle coat (clathrin, nonclathrin, caveolae, and macropinosome) (10) . The most extensively studied mechanism for receptor-mediated endocytosis occurs by means of the clathrin-coated pits and vesicles (11) . Proteins like the arrestins and dynamins play important roles in the function of clathrin-coated pits. Arrestins have been shown to interact with clathrin (12) (13) (14) , the major protein component of clathrin-coated pits, as well as with the clathrin adaptor protein AP-2 (15) , and the N-ethylmaleimide-sensitive fusion protein (NSF) (16) . Furthermore, dynamin, a large GTPase, is involved in pinching off of clathrin-coated vesicles from the plasma membrane (17) (18) (19) (20) (21) (22) . Moreover, dynamin also has been localized in caveolae, and its GTPase activity also appears to be essential for budding of vesicles from these structures (23, 24) .
Although many studies have addressed the precise functions of proteins that mediate the complex process of clathrin-dependent internalization, additional factors that are required for this and other endocytic pathways remain to be defined. In an attempt to further delineate the role of GIT1 in regulating cell surface receptor function and trafficking, we examined the role of this newly appreciated GRK-interacting protein in the internalization of a variety of receptors.
Materials and Methods
Materials. Tissue culture media and FBS were obtained from Life Technologies (Rockville, MD). Isoproterenol, angiotensin II, antiFlag M2, and anti-c-myc mAbs, anti-mouse IgG-FITC-conjugated antibody, and monodansylcadaverine were purchased from Sigma. Vasoactive intestinal peptide and endothelin-1 were purchased from Peninsula Laboratories. Mouse anti-hemagglutinin (HA) 12CA5 mAb was obtained from Roche Molecular Biochemicals. Fluorescein-labeled transferrin and rhodamine-labeled goat antimouse antibodies were from Molecular Probes. Recombinant epidermal growth factor (EGF) was obtained from Calbiochem. Anti-human EGF receptor (clone 528) antibody was obtained from Santa Cruz Biotechnology.
Plasmids. The rat vasoactive intestinal peptide (VIP) 1 receptor (25) was amplified from rat liver cDNA library and subcloned into the pcDNA1͞Amp vector (Invitrogen). The pcDNA1͞ Amp-Flag-VIP 1 receptor was generated by amplifying the entire receptor cDNA using an oligonucleotide primer that inserted a HA signal sequence and Flag epitope (DYKDDDDA) immediately before amino acid 1 of the mature receptor, replacing the endogenous signal sequence, as described for the ␤ 2 AR (26).
The pBK-Flag-A 2B was prepared in the same manner from the corresponding human wild-type receptor cDNA. The pRK5-HA-M1 and pRK5-HA-M2 muscarinic acetylcholine receptors were generated by amplifying the receptor cDNAs using oligonucleotide primers that inserted HA signal sequence and HA epitope (YPYDVPDYA, recognized by the 12CA5 mAb) immediately after the initiator methionine. All constructs were verified by sequencing. The pBK-Flag-␤ 2 AR (7), pBK-GIT1-Flag (7), pcDNA3-Flag-␤ 1 adrenergic receptor (27) , pcDNA3-HA--opioid receptor (28), pcDNA1-Flag-endothelin B receptor (29) , and pcDNA1-HA-angiotensin 1A receptor (30) have been described.
Cell Culture and Transfection. HEK 293 cells were maintained in MEM supplemented with 10% FBS, 100 units͞ml penicillin G, and 100 g͞ml streptomycin sulfate at 37°C, 5% CO 2 . Before transfection, cells were grown to 60-75% confluency. Cells were transiently transfected overnight in 100-mm dishes (Falcon) with 12 g of total plasmid DNA using calcium phosphate precipitation (31) . After transfection (Ϸ16 h), the cells were incubated with fresh medium and allowed to recover for 8 h before being reseeded into 12-or 6-well dishes. The generation of the GIT1 stable cell line has been described (7).
Sequestration Assays. Receptor sequestration was determined by flow cytometry as described (32) Transferrin Uptake Assay. Transferrin uptake assays were performed as described (33) . Briefly, GIT1-Flag and dynamin II K 44 A were transfected into COS 7 cells on coverslips using Lipofectamine (GIBCO͞BRL) according to the manufacturer's instructions. Forty-eight hours after transfection, cells were serum-starved for 1 h, labeled for 15 min with 20 g͞ml of fluorescein-labeled transferrin, rinsed, and fixed with 3% paraformaldehyde for 25 min. The cells then were permeabilized for 5 min with acetone (Ϫ20°C) and immunostained with anti-Flag or anti-c-myc antibodies and rhodamine-labeled anti-mouse IgG secondary antibodies. Digital fluorescence images were acquired with a Photometrics (Tuscon, AZ) cooled charge-coupled device mounted on a Zeiss Axiovert 135 epifluorescence microscope.
Data Analysis. The mean and SEM are expressed for values obtained from the number of separate experiments indicated. Statistical analysis was performed by a two-way ANOVA followed by an unpaired Student's t test.
Results
We recently demonstrated that GIT1 overexpression in HEK 293 cells leads to a marked reduction in cAMP signaling ability of the endogenous ␤ 2 AR along with increased receptor phosphorylation and reduced agonist-dependent receptor sequestration from the cell surface (7). We proposed that GIT1 overexpression inhibits agonist-promoted internalization of the ␤ 2 AR, which in turn leads to accumulation of phosphorylated receptors and reduced signaling capacity. To explore the generality of this receptor modulatory activity of GIT1, we first examined the ability of GIT1 overexpression to inhibit the agonist-promoted internalization of other G s -coupled receptors. Using transient expression of Flag or HA epitope-tagged receptor cDNAs, cell surface receptor number was assessed before and after a 30-min agonist stimulation (Fig. 1a) . Similar to the ␤ 2 AR, the agoniststimulated internalization of the adenosine 2B and ␤ 1 -adrenergic receptors was markedly reduced in GIT1-overexpressing cells. In contrast, the agonist-promoted endocytosis of the VIP 1 receptor was not affected by GIT1 overexpression (Fig. 1a) . Furthermore, stable overexpression of GIT1 reduced cAMP production stimulated by activated endogenously expressed adenosine 2B receptor, as well as the ␤ 2 AR, but not by the VIP 1 receptor (data not shown). Taken together, these results provide strong evidence that the inhibitory action of GIT1 overexpression on receptor function is not specific to the ␤ 2 AR, but neither is it common to all G s -coupled receptors.
We next tested the ability of GIT1 overexpression to alter endocytosis of receptors coupled to distinct G proteins. We chose the G i -coupled -opioid receptor (OR) and M2 muscarinic receptor (MR), and the G q -coupled M1 MR, endothelin B receptor (ET B R), and angiotensin 1A receptor (AT 1A R). All five receptors underwent substantial agonist-promoted sequestration from the cell surface ( Fig. 1 b and c) . Agonist-dependent internalization of the OR and M1 MR was inhibited by GIT1 overexpression. However, agonist-stimulated endocytosis of the M2 MR, ET B R, and AT 1A R was not affected by GIT1. These results show that the ability of GIT1 to inhibit receptor endocytosis does not correlate with the type of G protein to which a receptor couples, because at least some G s -, G i -, and G q -coupled receptors can be regulated by GIT1 overexpression, whereas others are not.
Studies of endocytosis of heptahelical receptors have demonstrated that several distinct pathways of sequestration from the cell surface exist. These pathways differ in their sensitivity to various inhibitors, such as mutants of the ␤-arrestin1 protein, A to affect internalization of several heptahelical receptors. Of the five receptors affected by GIT1 overexpression, ␤ 2 AR, ␤ 1 AR, A 2B R, OR, and M1 MR, all five also were inhibited by both ␤-arrestin and dynamindominant negative mutants (Fig. 2) . Of the four receptors unaffected by GIT1, VIP 1 R, ET B R, M2 MR, and AT 1A R, all were unaffected by the two ␤-arrestin mutants (Fig. 2) . Interestingly, the sequestration of the VIP 1 R and the ET B R was substantially inhibited by dynamin 1 K 44 A, whereas that of the M2 MR and AT 1A R was not (Fig. 2) . Thus, sensitivity to GIT1 appears correlated with sensitivity to ␤-arrestin mutants. However, sensitivity to dynamin K 44 A, while occurring for all GIT1-sensitive receptors, appears to be a feature of a wider class of G protein-coupled receptors ( Table 1) .
The sequestration of the ␤ 2 AR has been reported previously to use the clathrin-coated pit pathway (4, 12, 43) , suggesting that GIT1 sensitivity may correlate with receptor sequestration by means of a ␤-arrestin-and dynamin-sensitive clathrin-coated pit pathway. As a first step to show that the GIT1-sensitive sequestration pathway is indeed the clathrin-coated pit pathway, we examined receptor sequestration in cells treated with 400 M monodansylcadaverine (MDC), which has been reported to stabilize clathrin cage assembly, thus inhibiting internalization (44) . We tested the effect of MDC treatment on one representative receptor from each of the sequestration classes: namely, the ␤ 2 AR (sensitive to GIT1, and mutants of ␤-arrestin and dynamin), the ET B R (sensitive to the dynamin mutant, but not GIT1 or mutants of ␤-arrestin), and the AT 1A R (insensitive to GIT1 or mutants of ␤-arrestin and dynamin). A 30-min pretreatment of the cells with MDC substantially inhibited agonistpromoted sequestration of the ␤ 2 AR, but was ineffective in inhibiting agonist-stimulated sequestration of either the ET B R or AT 1A R (Fig. 3) . These data suggest that the pattern of inhibition defined by sensitivity to GIT1, ␤-arrestin mutants, and the dynamin mutant may indeed fingerprint the clathrindependent pathway for receptor internalization.
Finally, to distinguish whether GIT1 plays a specific role in agonist-dependent G protein-coupled receptor internalization through the clathrin-coated pit pathway or more generally in clathrin-mediated endocytosis, we examined the effect of GIT1 overexpression on two non-G protein-coupled receptors known to internalize by means of the clathrin pits: the EGF receptor, a tyrosine kinase receptor, and the transferrin receptor, a constitutively recycling receptor (45) . Signaling receptors, such as receptor tyrosine kinases and G protein-coupled receptors, require ligand binding for internalization. Similar to most G protein-coupled receptors, phosphorylation of the EGF receptor is necessary for internalization (10, 46, 47) . Furthermore, agonist-promoted internalization of G protein-coupled receptors and tyrosine kinase receptors is associated with the recruitment of clathrin to the plasma membrane (12, (48) (49) (50) . First, we examined the effect of GIT1 on EGF receptor internalization.
Overexpression of GIT1, as well as dynamin K 44 A, significantly reduced agonist-promoted sequestration of the EGF receptor from the cell surface (Fig. 4) . These results demonstrate that the effect of GIT1 on agonist-promoted sequestration of receptors is not limited to G protein-coupled receptors.
Secondly, we examined whether GIT1 overexpression affected transferrin uptake through the transferrin receptor. This receptor is continually removed from the cell surface through internalization in clathrin-coated vesicles. However, in contrast to G protein-coupled receptors and the EGF receptor, recruitment of this receptor to the pits and its subsequent internalization does not require occupancy of the receptor by transferrin. Immunofluorescence microscopy was used to assess changes in the transferrin accumulation by measuring FITC staining in cells overexpressing GIT1 or dynamin II K 44 A. Fig. 5a shows a representative field of COS 7 cells overexpressing GIT1-Flag Fig. 5b , where GIT1-Flag overexpression does not affect FITCtransferrin uptake, whereas dynamin-dominant negative protein overexpression markedly inhibits uptake. These results show that constitutive internalization through clathrin-coated pits is not affected by GIT1. Thus, the locus of GIT1 action appears to be consistent with an inhibition of agonist-activated receptor recruitment to or internalization by means of the clathrin-coated pits, rather than an inhibition of clathrin-coated pit formation and͞or internalization in general.
Discussion
In the present work, we demonstrate that GIT1 is involved in signaling and trafficking of G protein-coupled receptors that are internalized by means of the clathrin-coated pit pathway, but not in the regulation of receptors that internalize by means of other mechanisms. Considerable efforts have been made to define the sequence of events initiating and leading to the agoniststimulated sequestration of G protein-coupled receptors. The use of dominant negative mutant proteins and biochemical inhibitors has been very helpful in delineating the role of numerous proteins in endocytic pathways. For example, recent studies have revealed an involvement of the ␤-arrestin and dynamin proteins for at least some receptors.
In this study, we used two inhibitory mutants of ␤-arrestin and one of dynamin to elucidate the internalization pathways used by several receptor types, some of which are sensitive to GIT1 and others that are not. We have noted that receptors that sequester by means of a ␤-arrestin-sensitive pathway are also sensitive to GIT1, whereas receptors that sequester by means of a ␤-arrestininsensitive pathway are not sensitive to GIT1. Analysis of a number of receptor subtypes has allowed us to define three patterns of sequestration inhibitor sensitivity: (I) internalization through a GIT1-, ␤-arrestin-, and dynamin-sensitive pathway (␤ 2 AR, ␤ 1 AR, OR, M1 MR), (II) internalization through a dynamin-sensitive pathway that is insensitive to GIT1 or ␤-arrestin (VIP 1 R, ET B R), and (III) internalization through a pathway that is insensitive to GIT1, ␤-arrestin, or dynamin (AT 1A R, M2 MR) ( Table 1) .
According to the classification recently proposed by Bunemann et al. (51) , the GIT1-sensitive pathway (pathway I) corresponds to the clathrin-coated pit pathway. Our results suggest that the internalization mechanism sensitive to GIT1 is indeed the clathrin pathway because the biochemical inhibitor MDC also blocks endocytosis of the ␤ 2 AR, a representative of the class of receptor that is internalized by means of pathway I, whereas internalization of the ET B R (pathway II) and AT 1A R (pathway III) is not significantly affected. We conclude that the distinct patterns of inhibitor sensitivity that we have observed likely correspond to physically distinct cellular processes, although which precise vesicle coats are involved in the nonclathrin-mediated processes remains to be defined for each receptor type. We speculate that pathway II is the caveolae pathway because internalization of receptors in that class is sensitive to a mutant of dynamin. Dynamin has been shown to localize to caveolae structures (23, 24) , providing further evidence that this protein may be involved in caveolae-mediated endocytosis. Interestingly, the endothelin receptors have been shown to localize to caveolae (52, 53) in different cell types. Thus, it is possible that they use this pathway of internalization in a cell-specific manner. The dynamin-independent pathway used by the AT 1A R and M2 MR (pathway III) may require the participation of yet another type of internalization machinery, the components of which remain unidentified. However, Zhang et al. (38) have shown that the AT 1A R internalization can be enhanced by overexpression of ␤-arrestin 1, suggesting plasticity in the choice of endocytic pathways used by a receptor.
Interestingly, the role of GIT1 in endocytosis does not appear to be limited to G protein-coupled receptors but does appear to be specific for agonist-promoted clathrin-mediated internalization. Indeed, overexpression of GIT1 affects the sequestration of a tyrosine kinase receptor (EGF receptor), but not that of a constitutively recycling receptor (transferrin receptor), both of which internalize by means of the clathrincoated pit pathway. The major difference between agonistpromoted and constitutive endocytosis is that the adaptor recognition signal is constitutively accessible in the latter but cryptic in the former, until agonist binding has occurred. This model is attractive for the G protein-coupled receptors because GIT1 binds the GRKs that phosphorylate only activated G protein-coupled receptors (7). However, neither GIT1 nor GRKs are known to have any association with the EGF receptor. The link between activated signaling receptors (G protein-coupled receptors and tyrosine kinase receptors) and GIT1 provided by the GRKs or other adaptor proteins may be important for receptor recruitment to the clathrin-coated pits. Our results suggest that GIT1 may play a role in targeting activated receptors to clathrin-coated pits rather than in pit formation or internalization per se. However, further experimentation needs to be done to address this point.
Further, we previously have shown that the ARF GAP domain of GIT1 is critical for its ability to reduce endocytosis and signaling of the ␤ 2 AR (7), implying that ARF proteins are important for regulating clathrin-mediated endocytosis of G protein-coupled receptors. Moreover, a role for ARF6 in the internalization of the transferrin receptor has been shown previously (54) . It therefore was surprising that GIT1 did not affect transferrin receptor function. Perhaps, despite overexpression, GIT1 may require interaction with other signaling proteins for recruitment to the activated ARF6 pool on the plasma membrane, and is thus unable to alter transferrin receptor cycling. Moreover, Cao et al. (55) have suggested that distinct subpopulations of clathrin-coated pits are responsible for endocytosis of the ␤ 2 AR and the transferrin receptor. Ligand-induced endocytosis is likely to involve components different from those engaged by a constitutively cycling receptor.
In this study, we have defined the specificity of the GIT1 protein for regulating cell surface receptor internalization. Whether the effect of GIT1 solely depends on its ARF GAP activity remains to be defined. However, the study of ARF regulatory proteins like GIT1 will give us more insight into the precise role of these proteins in regulating well-defined internalization pathways such as the clathrin-coated pit endocytic pathway. GIT1 also provides a useful tool to distinguish the different routes of internalization used by G protein-coupled receptors. 
